SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Unquoted Biotechs
An SI Board Since July 2001
Posts SubjectMarks Bans
253 23 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
178Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics Tunigel bates-1/9/2007
177elusys.com Elusys Overview Elusys Therapeutics, Inc. is a privately-held biophaIan@SI-1/4/2007
176ChemoCentryx Appoints Juan Jaen, Ph.D., Senior Vice President, Drug Discovery Thnigel bates-1/4/2007
175Julie Olson goes from cutting deals at Pfizer to adjusting her Big Pharma attitutnsaf-12/18/2006
174The Boston Globe featured them today: investorshub.com Regards, DewDewDiligence_on_SI-12/18/2006
173Codon Devices Closes $20 Million Series B Financing Monday December 18, 9:00 am nigel bates-12/18/2006
172Trigen Begins Phase-1 Trial of Antiplatelet Agent: investorshub.comDewDiligence_on_SI-12/13/2006
171Genentech and AC Immune: Exclusive License Agreement AC Immune, Ltd. enters inigel bates-12/7/2006
170Gladstone: Part of the Univ of Ca, San Fran AD partnership with MRK; and severIan@SI-11/24/2006
169Ablynx Enters into a Research and License Agreement with Wyeth Monday November 6nigel bates-11/6/2006
168Unfortunately, I think the rats were on the equivalent of something like 100 botnigel bates-11/2/2006
167Hmmmm, so it's take a pill or have a couple glasses of wine. Tough decisionIan@SI-11/2/2006
166I didn't realise we needed an excuse. <i>Dominant Patent Estate and Knigel bates-11/2/2006
165As you may already know, this is related to resveratrol, the chief medical excustuck-11/2/2006
164Sirtris Announces Clinical Results from Phase 1 Trials of SRT501, a Sirtuin Thernigel bates-11/2/2006
163COPENHAGEN, Denmark, September 11, 2006. Symphogen announced today that the Euronigel bates-10/27/2006
162Abbey Pharmaceuticals, a startup biotechnology company focused on medications foIan@SI-10/23/2006
161orexigen.com Public release date: 22-Oct-2006 Contact: Stephen Gendel sgendel@Ian@SI-10/22/2006
160Astex Patents Granted Covering the Use of Key Human Cytochrome P450 Structures Tnigel bates-10/17/2006
159ViraBiotech: MAJOR Breakthrough in both treating and protecting from all currenIan@SI-10/4/2006
158Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamynigel bates-10/4/2006
157Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Mednigel bates-10/4/2006
156Didn't follow them myself, but noticed (after the event) that directors werenigel bates-10/3/2006
155I mean to mention them in misc biotechs:-) This is the only program I follow in dr.praveen-10/2/2006
154They are quoted - uk.finance.yahoo.com (and I wish I'd noticed the directornigel bates-10/2/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News